Autism Speaks | GenomeWeb

Autism Speaks

BioTeam has developed a web portal for the MSSNG repository that offers easy access to genomic, phenotype, and clinical data collected through the project.

David Glazer from Google Genomics provided an update on the MSSNG project, a collaboration between Autism Speaks, The Hospital for Sick Children in Toronto, and Google.

Genome sequences generated for the Autism Speaks MSSNG project provided evidence of genetic heterogeneity in 85 families, each containing two children affected by autism spectrum disorder.

NEW YORK (GenomeWeb) – Autism Speaks said today it will collaborate with Google to create a database of genomic information on autism spectrum disorder that will be an open resource for use by autism researchers and will be available via the Google Cloud Platform.

NEW YORK (GenomeWeb News) – Autism Speaks yesterday announced nine new winners of its Dennis Weatherstone Predoctoral Fellows grants, including three researchers studying some of the possible genetic and epigenetic factors involved in autism.

NEW YORK (GenomeWeb News) – Autism Speaks today announced a $3 million gift in support of its Autism Ten Thousand Genomes program (Aut10K) to sequence the world's largest collection of whole genomes of individuals with autism spectrum disorder and their families.

NEW YORK (GenomeWeb News) – Autism Speaks said today that its nonprofit affiliate Delivering Scientific Innovation for Autism (DELSIA) will provide $2 million for a biomarker discovery project with Seaside Therapeutics, a drug developer that plans to market a new personalized treatment.

By Molika Ashford
Advocacy group Autism Speaks has announced a partnership with Chinese genomics institute BGI to sequence the whole genomes of 10,000 individuals in families of children with autism spectrum disorder.


Kuwait says it will alter its law requiring citizens and visitors to provide DNA samples, New Scientist reports.

In Science this week: convergent evolution in bird hemoglobin, and more.

The Wall Street Journal speaks with patients affected by questionable test results from Theranos.

Researchers link variants in TACR3 to hot flashes during menopause, Live Science reports.